Illumina, Inc. (ILMN)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$289.56
+3.72%
Mkt Cap $40.46B
Analyst Ratings
Buy
18
Hold
7
Sell
6
Price Target (80 analysts)
$210.67
Range $155.00 – $260.00
Implied Upside
-27.2%
Consensus $210.67 vs current $289.56